North America Esoteric Testing Market Size By Test Type (Endocrinology, Infectious Disease & Immunology, Oncology, Toxicology, Neurology, Genomics), By Technology (Mass Spectrometry, Flow Cytometry, ELISA, Radioimmunoassay, Chemiluminescence, RT-PCR), Industry Analysis Report, Regional Outlook (U.S., Canada), Application Potential, Competitive Market Share & Forecast, 2019 - 2025

Published Date: May 2019 | Publisher: Graphical Research Report ID: GR1172 | Delivery : PDF

Report Content

Chapter 1.  Methodology

1.1. Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters      

1.2. Data sources

1.3. References & sources

1.3.1.  Secondary

1.3.2.  Primary

Chapter 2.  Executive Summary

2.1. North America esoteric testing industry summay, 2014 – 2025

2.1.1.  Regional trends

2.1.2.  Test-type trends

2.1.3.  Technology trends

Chapter 3.  Industry Insights

3.1. Industry segmentation

3.2. Industry outlook, 2014 - 2025

3.3. Major factor analysis

3.3.1.  Drivers

3.3.1.1. Technological advancements in esoteric testing

3.3.1.2. Rising occurrence of complex and rare medical disorders in the U.S

3.3.1.3. Increasing prevalence of cancer and infectious diseases

3.3.1.4. Growing demand for genomics and proteomics

3.3.1.5. Rising awareness for early disease detection

3.3.2.  Restraints & challenges

3.3.2.1.  Stringent regulatory framework

3.4. Types of business models

3.4.1. Mobile lab services

3.4.2. Full service diagnostics

3.4.3. Reference/consulting services

3.5. Regulatory landscape

3.5.1.  U.S.

3.6. Porter’s analysis

3.7. Competitive review, 2017

3.8. PEST analysis

Chapter 4. North America Esoteric Testing Market, By Test Type

4.1. Key trends in North America esoteric testing, by test type

4.2. Endocrinology esoteric testing

4.2.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.3. Infectious disease & immunology esoteric testing

4.3.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.4. Oncology

4.4.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.5. Toxicology

4.5.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.6. Neurology

4.6.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.7. Genomics

4.7.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.8. Others

4.8.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

Chapter 5. North America Esoteric Testing Market, By Technology

5.1. Key trends in North America esoteric testing, by technology

5.2. Mass spectrometry

5.2.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.3. Flow cytometry

5.3.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.4. ELISA

5.4.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.5. Radioimmunoassay

5.5.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.6. Chemiluminescense

5.6.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.7. RT-PCR

5.7.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.8. Others

5.8.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

Chapter 6. North America Esoteric Testing Market, By Country

6.1. Key trends in North America esoteric testing, by country

6.2. U.S.

6.2.1.   Market estimates and forecast, by test type, 2014 – 2025

6.2.2.   Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

6.2.3.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

6.3. Canada

6.3.1.   Market estimates and forecast, by test type, 2014 – 2025

6.3.2.   Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

6.3.3.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

Chapter 7.  Company Profiles

7.1. ACM Global Laboratories

7.1.1.  Business overview

7.1.2.  Financial data

7.1.3.  Product landscape

7.1.4.  Strategic outlook

7.1.5.  SWOT analysis

7.2. American Esoteric Laboratories (Sonic Healthcare Limited)

7.2.1.  Business overview

7.2.2.  Financial data

7.2.3.  Product landscape

7.2.4.  Strategic outlook

7.2.5.  SWOT analysis

7.3. Arup Laboratories

7.3.1.  Business overview

7.3.2.  Financial data

7.3.3.  Product landscape

7.3.4.  Strategic outlook

7.3.5.  SWOT analysis

7.4. bioMONTR

7.4.1.  Business overview

7.4.2.  Financial data

7.4.3.  Product landscape

7.4.4.  Strategic outlook

7.4.5.  SWOT analysis

7.5. Fulgent Genetics Inc.

7.5.1.  Business overview

7.5.2.  Financial data

7.5.3.  Product landscape

7.5.4.  Strategic outlook

7.5.5.  SWOT analysis

7.6. Genomic Health

7.6.1.  Business overview

7.6.2.  Financial data

7.6.3.  Product landscape

7.6.4.  Strategic outlook

7.6.5.  SWOT analysis

7.7. Invitae Corporation

7.7.1.  Business overview

7.7.2.  Financial data

7.7.3.  Product landscape

7.7.4.  Strategic outlook

7.7.5.  SWOT analysis

7.8. Laboratory Corporation of America

7.8.1.  Business overview

7.8.2.  Financial data

7.8.3.  Product landscape

7.8.4.  Strategic outlook

7.8.5.  SWOT analysis

7.9. Mayo Medical Laboratories

7.9.1.  Business overview

7.9.2.  Financial data

7.9.3.  Product landscape

7.9.4.  Strategic outlook

7.9.5.  SWOT analysis

7.10. Miraca Holdings Inc.

7.10.1. Business overview

7.10.2. Financial data

7.10.3. Product landscape

7.10.4. Strategic outlook

7.10.5. SWOT analysis

7.11. Myriad Genetics, Inc.

7.11.1. Business overview

7.11.2. Financial data

7.11.3. Product landscape

7.11.4. Strategic outlook

7.11.5. SWOT analysis

7.12.  Nordic Laboratories

7.12.1. Business overview

7.12.2. Financial data

7.12.3. Product landscape

7.12.4. Strategic outlook

7.12.5. SWOT analysis

7.13. OPKO Health Inc.

7.13.1. Business overview

7.13.2. Financial data

7.13.3. Product landscape

7.13.4. Strategic outlook

7.13.5. SWOT analysis

7.14. Quest Diagnostics, Inc.

7.14.1. Business overview

7.14.2. Financial data

7.14.3. Product landscape

7.14.4. Strategic outlook

7.14.5. SWOT analysis

Data Tables

TABLE 1.   North America market estimates by country, (USD Mn), 2014 - 2018

TABLE 2.   North America market forecast by country, (USD Mn), 2019 - 2025

TABLE 3.   North America market estimates by test-type, (USD Mn), 2014 – 2018

TABLE 4.   North America market forecast by test-type, (USD Mn), 2019 – 2025

TABLE 5.   North America market estimates by technology, (USD Mn), 2014 - 2018

TABLE 6.   North America market forecast by technology, (USD Mn), 2019 - 2025

TABLE 7.   Competition review

TABLE 8.   North America endocrinology esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 9.   North America endocrinology esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 10. North America infectious disease & immunology esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 11. North America infectious disease & immunology esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 12. North America oncology esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 13. North America oncology esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 14. North America toxicology esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 15. North America toxicology esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 16. North America neurology esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 17. North America neurology esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 18. North America genomics esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 19. North America genomics esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 20. North America other esoteric testing type market estimates, (USD Mn), 2014 - 2018

TABLE 21. North America other esoteric testing type market forecast, (USD Mn), 2019 - 2025

TABLE 22. North America mass spectrometry esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 23. North America mass spectrometry esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 24. North America flow cytometry esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 25. North America flow cytometry esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 26. North America ELISA esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 27. North America ELISA esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 28. North America radioimmunoassay esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 29. North America radioimmunoassay esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 30. North America chemiluminescence esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 31. North America chemiluminescence esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 32. North America RT-PCR esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 33. North America RT-PCR esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 34. North America other esoteric testing technologies market estimates, (USD Mn), 2014 - 2018

TABLE 35. North America other esoteric testing technologies market forecast, (USD Mn), 2019 - 2025

TABLE 36. U.S. esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 37. U.S. esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 38. U.S. esoteric testing market estimates, by test-type, (USD Mn), 2014 - 2018

TABLE 39. U.S. esoteric testing market forecast, by test-type, (USD Mn), 2019 - 2025

TABLE 40. U.S. esoteric testing market estimates, by technology, (USD Mn), 2014 - 2018

TABLE 41. U.S. esoteric testing market forecast, by technology, (USD Mn), 2019 - 2025

TABLE 42. Canada esoteric testing market estimates, (USD Mn), 2014 - 2018

TABLE 43. Canada esoteric testing market forecast, (USD Mn), 2019 - 2025

TABLE 44. Canada esoteric testing market estimates, by test-type, (USD Mn), 2014 - 2018

TABLE 45. Canada esoteric testing market forecast, by test-type, (USD Mn), 2019 - 2025

TABLE 46. Canada esoteric testing market estimates, by technology, (USD Mn), 2014 - 2018

TABLE 47. Canada esoteric testing market forecast, by technology, (USD Mn), 2019 - 2025

Charts & Figures

FIG 1. Industry segmentation

FIG 2. North America esoteric testing industry outlook, 2014 - 2025

FIG 3. Porter’s analysis

FIG 4. PEST analysis

Select License

North America Esoteric Testing Market Growth Analysis Report by 2025


Related Reports
Why Choose us?